Literature DB >> 32515974

Spiky Nanostructures with Geometry-matching Topography for Virus Inhibition.

Chuanxiong Nie1,2, Marlena Stadtmüller2, Hua Yang3, Yi Xia1, Thorsten Wolff2, Chong Cheng1,4, Rainer Haag1.   

Abstract

Geometry-matching has been known to benefit the formation of stable biological interactions in natural systems. Herein, we report that the spiky nanostructures with matched topography to the influenza A virus (IAV) virions could be used to design next-generation advanced virus inhibitors. We demonstrated that nanostructures with spikes between 5 and 10 nm bind significantly better to virions than smooth nanoparticles, due to the short spikes inserting into the gaps of glycoproteins of the IAV virion. Furthermore, an erythrocyte membrane (EM) was coated to target the IAV, and the obtained EM-coated nanostructures could efficiently prevent IAV virion binding to the cells and inhibit subsequent infection. In a postinfection study, the EM-coated nanostructures reduced >99.9% virus replication at the cellular nontoxic dosage. We predict that such a combination of geometry-matching topography and cellular membrane coating will also push forward the development of nanoinhibitors for other virus strains, including SARS-CoV-2.

Entities:  

Keywords:  Geometry-matching principle; cellular membrane coating; spiky nanostructures; virus binding and inhibition

Mesh:

Substances:

Year:  2020        PMID: 32515974     DOI: 10.1021/acs.nanolett.0c01723

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  10 in total

1.  Foscarnet-Type Inorganic-Organic Hybrid Nanoparticles for Effective Antiviral Therapy.

Authors:  Mikhail Khorenko; Ulfert Rand; Luka Cicin-Sain; Claus Feldmann
Journal:  ACS Biomater Sci Eng       Date:  2022-03-28

2.  Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2.

Authors:  Rüdiger Groß; Lívia Mesquita Dias Loiola; Leila Issmail; Nadja Uhlig; Valentina Eberlein; Carina Conzelmann; Lia-Raluca Olari; Lena Rauch; Jan Lawrenz; Tatjana Weil; Janis A Müller; Mateus Borba Cardoso; Andrea Gilg; Olivia Larsson; Urban Höglund; Sandra Axberg Pålsson; Anna Selch Tvilum; Kaja Borup Løvschall; Maria M Kristensen; Anna-Lena Spetz; Fortune Hontonnou; Marie Galloux; Thomas Grunwald; Alexander N Zelikin; Jan Münch
Journal:  Adv Sci (Weinh)       Date:  2022-05-11       Impact factor: 17.521

Review 3.  Designer DNA nanostructures for viral inhibition.

Authors:  Shaokang Ren; Keith Fraser; Lili Kuo; Neha Chauhan; Addison T Adrian; Fuming Zhang; Robert J Linhardt; Paul S Kwon; Xing Wang
Journal:  Nat Protoc       Date:  2022-01-10       Impact factor: 17.021

4.  Systematic design of cell membrane coating to improve tumor targeting of nanoparticles.

Authors:  Lizhi Liu; Dingyi Pan; Sheng Chen; Maria-Viola Martikainen; Anna Kårlund; Jing Ke; Herkko Pulkkinen; Hanna Ruhanen; Marjut Roponen; Reijo Käkelä; Wujun Xu; Jie Wang; Vesa-Pekka Lehto
Journal:  Nat Commun       Date:  2022-10-19       Impact factor: 17.694

5.  Spiky nanostructures for virus inhibition and infection prevention.

Authors:  Chuanxiong Nie; Lang Ma; Hongrong Luo; Jinku Bao; Chong Cheng
Journal:  Smart Mater Med       Date:  2020-07-16

Review 6.  Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control.

Authors:  Kai-Chieh Yang; Jung-Chen Lin; Hsiao-Han Tsai; Chung-Yao Hsu; Vicky Shih; Che-Ming Jack Hu
Journal:  Drug Deliv Transl Res       Date:  2021-03-21       Impact factor: 4.617

Review 7.  Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary.

Authors:  Shujing Xu; Dang Ding; Xujie Zhang; Lin Sun; Dongwei Kang; Boshi Huang; Xinyong Liu; Peng Zhan
Journal:  Molecules       Date:  2022-01-27       Impact factor: 4.411

Review 8.  Nanotechnology Toolkit for Combating COVID-19 and Beyond.

Authors:  Giredhar Muthiah; Ankita Sarkar; Shounak Roy; Prem Singh; Praveen Kumar; Keshav Bhardwaj; Amit Jaiswal
Journal:  ChemNanoMat       Date:  2022-03-10       Impact factor: 3.820

Review 9.  Nanoparticles in clinical trials of COVID-19: An update.

Authors:  Abdur Rauf; Tareq Abu-Izneid; Anees Ahmed Khalil; Nabia Hafeez; Ahmed Olatunde; Mominur Rahman; Prabhakar Semwal; Yahya Saleh Al-Awthan; Omar Salem Bahattab; Ishaq N Khan; Muhammad Arslan Khan; Rohit Sharma
Journal:  Int J Surg       Date:  2022-08-08       Impact factor: 13.400

Review 10.  Nanotechnology for the management of COVID-19 during the pandemic and in the post-pandemic era.

Authors:  Chun Xu; Chang Lei; Sepanta Hosseinpour; Saso Ivanovski; Laurence J Walsh; Ali Khademhosseini
Journal:  Natl Sci Rev       Date:  2022-06-27       Impact factor: 23.178

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.